Secondary Benefits The pill contains the same medicine as the injectable, and its highly likely that the health benefits will be the same, Dr
Zhang Y, Zhang Q, Bai Y, Zheng H, Ji L, Zhu X et al (2023) Glycogen synthesis kinase-3 involves in the analgesic effect of liraglutide on diabetic neuropathic pain
Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of 30 kg/m 2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)
95% CI, 0.32 to 0.60) suicidal ideation compared to non-GLP-1 RAs anti-obesity treatments [80]
Summary In conclusion, the landscape of weight loss medications is rapidly evolving, offering new and promising options for individuals seeking to manage their weight and improve their health
However, obesity is a global health challenge with few drug options (100)